Original Paper

Blood Component Transfusion in Primary Coronary Artery Bypass Surgery in Kuwait
Fahad Al-Shammari^a, Ahmed Al-Duaij^a, Jamal Al-Fadhli^a, Emad Al-Sahwaf^b, Riyad Tarazi^a

Departments of
^aCardiac Surgery and
^bAnesthesia, Chest Diseases Hospital, Kuwait

Address of Corresponding Author

Med Princ Pract 2005;14:83-86 (DOI: 10.1159/000083916)

  Key Words

• Primary coronary artery bypass surgery
• Blood products
• Cost of transfusion

  Abstract

Objective: The aims of this study were to determine the rate of blood product transfusion, associated perioperative factors and cost of such blood product transfusion in primary coronary artery bypass surgery (CABG). Subjects and Methods:The medical records of 159 consecutive primary CABG patients (142 male, 17 female) from January 1, 2003 to June 30, 2003 at Chest Diseases Hospital, Kuwait, were reviewed. Urgent and emergency cases were included. Results: The mean age of the patients was 57.2 (range 36-77 years). Overall, 128 (80.5%) patients received blood product transfusion during primary CABG: 113 (70.5%) packed red blood cells (RBC), 54 (33.9%) fresh frozen plasma, and 13 (8%) platelets. Overall, 23 patients (12.6%) received more than two RBC transfusions intraoperatively. Significant factors for intraoperative RBC transfusion were: age >60 years, female gender, preoperative hemoglobin <12 g/dl, and 3 or more coronary bypass grafts constructed. One hundred and fifty-nine patients consumed 342 units of RBC at an average of 2.1 RBC units per patient. The cost per patient was 80 Kuwaiti dinar (KD; USD 240). Conclusion:The findings indicate a high rate of blood component transfusion in primary CABG patients in Kuwait that could expose the patients to the possible adverse effects, and such transfusions have high economic impact.

Copyright © 2005 S. Karger AG, Basel

  References

1.

Goodnough LT, Johnston MF, Toy PTY: The variability of transfusion practice in coronary artery bypass surgery. JAMA 1991;265:86-90.

2.

Stover EP, Siegel LC, Parks R, Levin J, Body SC, Maddi R, D'Ambra MN, Mangano DT, Spiess BD: Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines. Anesthesiology 1998;88:327-333.

3.

Chamberland ME: Emerging infectious agents: Do they pose a risk to the safety of transfused blood and blood products? Clin Infect Dis 2002;34:797-805.

4.

Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB, Arduino MJ, Holt SC, Carson LA, Banerjee SN, Jarvis WR: Transfusion-transmitted bacterial infection in the United States, 1998 through 2000.Transfusion 2001;41:1493-1499.

5.

Chelemer SB, Prato BS, Cox PM Jr, O'Connor GT, Morton JR: Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann Thorac Surg 2002;73:138-142.

6.

Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, Clarke G, Ambuso DR: Transfusion-related acute lung injury: Epidemiology and a prospective analysis of etiologic factors. Blood 2003;101:454-462.

7.

Kytola L, Nuutinen L, Myllyla G: Transfusion policies in coronary artery bypass: A nationwide survey in Finland. Acta Anaesthesiol Scand 1998;42:178-183.

8.

McGill N, O'Shaughnessy D, Pickering R, Herbertson M, Gill R: Mechanical methods of reducing blood transfusion in cardiac surgery: Randomized controlled trial. BMJ 2002;324:1299.

9.

Litmathe J, Boeken U, Feindt P, Gams E: Predictors of homologous blood transfusion for patients undergoing open heart surgery. Thorac Cardiovasc Surg 2003;51:17-21.

10.

Karkouti K, Cohen MM, McCluskey SA, Sher GD: A multivariable model for predicting the need for blood transfusion in patients undergoing first-time elective coronary bypass surgery. Transfusion 2001;41:1193-1203.

11.

Parr KG, Patel MA, Dekker R, Levin R, Glynn R, Avorn J, Morse DS: Multivariate predictors of blood product use in cardiac surgery. Cardiothorac Vasc Anesth 2003;17:176-181.

12.

Paone G, Silverman NA: The paradox of on-bypass transfusion thresholds in blood conservation. Circulation 1997;96(suppl 9):II-205-208.

13.

Bracey AW, Radovancevic R, Riggs SA, Houston S, Cozart H, Vaughn WK, Radovancevic B, McAllister HA Jr, Cooley DA: Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patients outcome. Transfusion 1999;39:1070-1077.

14.

Helm RE, Rosengart TK, Gomez M, Klemperer JD, DeBois WJ, Velasco F, Gold JP, Altorki NK, Lang S, Thomas S, Isom OW, Krieger KH: Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion. Ann Thorac Surg 1998;65:125-136.

15.

Ferraris VA, Ferraris SP, Joseph O, Wehner P, Mentzer RM Jr: Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg 2002;235:820-827.

16.

Janssens M, Hartstein G, David JL: Reduction in requirements for allogeneic blood products: Pharmacologic methods. Ann Thorac Surg 1996;62:1944-1950.

17.

Shapira OM, Aldea GS, Treanor PR, Chartrand RM, DeAndrade KM, Lazar HL, Shemin RJ: Reduction of allogeneic blood transfusions after open heart operations by lowering cardiopulmonary bypass prime volume. Ann Thorac Surg 1998;65:724-730.

18.

Sowade O, Warnke H, Scigalla P, Sowade B, Franke W, Messinger D, Gross J: Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood 1997;89:411-418.

19.

Van der Linden P, De Hert S, Daper A, Trenchant A, Jacobs D, De Boelpaepe C, Kimbimbi P, Defrance P, Simoens G: A standardized multidisciplinary approach reduces the use of allogeneic blood products in patients undergoing cardiac surgery. Can J Anaesth 2001;48:894-901.

20.

Goodnough LT, Soegiarso RW, Birkmeyer JD, Welch HG: Economic impact of inappropriate blood transfusions in coronary artery bypass graft surgery. Am J Med 1993;94:509-514.

  Author Contacts

Dr. Fahad Al-Shammari
PO Box 29518
13113 Safat (Kuwait)
Tel. +965 4830138, Fax +965 4821265
E-Mail fadawad@yahoo.com

  Article Information

Received: August 31, 2003
Revised: February 8, 2004
Published online: July 09, 2008
Number of Print Pages : 4
Number of Figures : 0, Number of Tables : 3, Number of References : 20

  Publication Details

Medical Principles and Practice (International Journal of the Kuwait University Health Sciences Centre)

Vol. 14, No. 2, Year 2005 (Cover Date: March-April 2005)

Journal Editor: Al Awadi, F. (Kuwait)
ISSN: 1011-7571 (Print), eISSN: 1423-0151 (Online)

For additional information: http://www.karger.com/mpp

  Drug Dosage / Copyright

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.